Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Sep 21 EFFECT Notice of effectiveness
-
15 Sep 21 POS AM Prospectus update (post-effective amendment)
- 13 Aug 21 424B3 Prospectus supplement
- 12 Aug 21 EFFECT Notice of effectiveness
- 9 Aug 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 3 Aug 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 16 Jul 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 28 Jun 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 14 May 21 S-4 Registration of securities issued in business combination transactions
DNA similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 14, 2021, with respect to the consolidated financial statements of Ginkgo Bioworks, Inc. in Post-Effective Amendment No. 1 to the Registration Statement (Form S-4 No. 333-256121) and related Prospectus of Soaring Eagle Acquisition Corp. for the registration of shares of its common stock and warrants to purchase shares of its common stock.
/s/ Ernst & Young LLP |
Boston, Massachusetts |
September 15, 2021 |